$PRGO is a publicly traded company in the Healthcare sector. This company operates across Healthcare and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 1 active Congressional signal mentioning $PRGO, including 1 bill. The current legislative sentiment leans bearish, with regulatory or policy headwinds potentially affecting performance.
$PRGO is currently facing 1 active congressional signal tracked by HillSignal. With 0 bullish, and 1 bearish signal, the average legislative impact score is 5.0/10. Key sectors affected include Healthcare and Manufacturing. Recent major catalysts include Stop Corporate Inversions Act of 2026. Below is the complete tracker of government activity affecting $PRGO’s market performance.
The Stop Corporate Inversions Act (S3847) would retroactively tax inverted companies as domestic corporations, directly hitting MDT, PRGO, and ALLE with $40M to $1.2B in annual tax increases. Market prices already discount this risk: all three are near 52-week lows. The bill is early-stage but has a companion in the House, indicating legislative momentum. Investors holding these names face binary tax-expense risk with limited upside until the bill's path clarifies.